Log in  First Connection?

Systemic DiseasesArchives

Incidence of glaucoma in patients with systemic lupus erythematosus: a nationwide cohort study in South Korea

 Published on 12/12/2025 |  Original article (Full-text)  | Ji Hong Kim et al. | British Journal of Ophthalmology 2025; aop:10.1136/bjo-2025-327897

Data may be obtained from a third party and are not publicly available. This study used data from the Korean National Health Insurance Service (NHIS), which are not publicly available due to data protection regulations. Access to these data requires approval from the NHIS and is limited to authorised...

Urinary acetylated protein as a biomarker of lupus nephritis: a prospective cohort study

 Published on 05/12/2025 |  Original article (Full-text)  | Lee Yeo-Jin et al. | Arthritis Research & Therapy 2025; 27(1): 220

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by recurrent flares, leading to progressive deterioration of multiple organ systems, including the kidneys, skin, joints, lungs, bowel, and central nervous system [1]. Among these manifestations, lupus nephritis (LN) develops...

Autoimmune aplastic anemia- a rare and devastating presentation of Systemic Lupus Erythematosus – a case report

 Published on 28/11/2025 |  Original article (Full-text)  | Das Dhriti Sundar et al. | BMC Rheumatology 2025; 9(1): 138

Systemic lupus Erythematous (SLE) is the prototype of autoimmune systemic rheumatic disease with variable systemic manifestations. The haematological features range from anemia, leukopenia, thrombocytopenia to the rarer manifestations such as thrombotic thrombocytopenic purpura, autoimmune myelofibrosis,...

Inflammation-related proteomics of extracellular vesicles as novel biomarkers for systemic lupus erythematosus revealed by proximity extension assay

 Published on 21/11/2025 |  Original article (Full-text)  | Zhan Shoubin et al. | Arthritis Research & Therapy 2025; 27(1): 211

Systemic lupus erythematosus (SLE) is a complex, heterogeneous, and debilitating autoimmune disease characterized by the production of autoantibodies and the deposition of immune complexes [1]. Both innate and adaptive immune dysregulation contribute to its pathogenesis, leading to complement activation,...

Juvenile systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome: a case report and literature review

 Published on 14/11/2025 |  Original article (Full-text)  | Luo Man et al. | Orphanet Journal of Rare Diseases 2025; 20(1): 564

Posterior reversible encephalopathy syndrome (PRES) is an acute or subacute encephalopathy syndrome that primarily manifests as headaches, seizures, and visual disturbances. The main causes of PRES include hypertension, end-stage renal disease, preeclampsia or eclampsia, systemic lupus erythematosus,...